Atara Biotherapeutics, Inc.
NASDAQ:ATRA
7.87 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 25.987 | 92.942 | 106.084 | 200.404 | 74.317 | 60.698 | 79.223 | 47.968 | 23.746 | 21.897 | 51.615 | 4.207 |
| Short Term Investments
| 25.884 | 149.877 | 264.984 | 300.255 | 184.792 | 248.933 | 86.873 | 207.714 | 296.736 | 82.219 | 0 | 0 |
| Cash and Short Term Investments
| 51.871 | 242.819 | 371.068 | 500.659 | 259.109 | 309.631 | 166.096 | 255.682 | 320.482 | 104.116 | 51.615 | 4.207 |
| Net Receivables
| 34.108 | 40.221 | 0.986 | 1.25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 9.706 | 1.586 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 6.184 | 10.308 | 12.567 | 21.364 | 13.883 | 11.858 | 6.094 | 4.871 | 4.115 | 1.91 | 0.193 | 0.035 |
| Total Current Assets
| 101.869 | 295.08 | 384.621 | 523.273 | 272.992 | 321.489 | 172.19 | 260.553 | 324.597 | 106.026 | 51.808 | 4.242 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 58.791 | 74.322 | 79.939 | 62.82 | 68.183 | 68.576 | 44.129 | 3.259 | 0.27 | 0.048 | 0.008 | 0.009 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 4.844 | 7.018 | 2.367 | 0.827 | 0.567 | 0.574 | 0.26 | 0.102 | 0.108 | 0.048 | 0.012 | 0.039 |
| Total Non-Current Assets
| 63.635 | 81.34 | 83.506 | 64.847 | 69.95 | 70.35 | 45.589 | 3.361 | 0.378 | 0.096 | 0.02 | 0.048 |
| Total Assets
| 165.504 | 376.42 | 468.127 | 588.12 | 342.942 | 391.839 | 217.779 | 263.914 | 324.975 | 106.122 | 51.828 | 4.29 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 3.684 | 6.871 | 17.368 | 7.118 | 7.963 | 3.719 | 14.711 | 2.778 | 1.445 | 0.44 | 0.606 | 0.121 |
| Short Term Debt
| 12.179 | 13.64 | 2.753 | 1.985 | 1.581 | 0.49 | 0.5 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.001 | 0.155 | 0.007 |
| Deferred Revenue
| 77.833 | 8 | 40.76 | 33.455 | 21.466 | -0.49 | -0.5 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 48.53 | 50.405 | 44.905 | 40.343 | 5.733 | 36.26 | 12.935 | 6.897 | 8.264 | 2.284 | 0.918 | 1.181 |
| Total Current Liabilities
| 142.226 | 78.916 | 105.786 | 82.901 | 36.743 | 39.979 | 27.646 | 9.675 | 9.709 | 2.724 | 1.524 | 1.302 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 45.693 | 58.064 | 25.518 | 13.041 | 14.136 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 37.562 | 77 | 55.708 | 27.795 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 39.254 | 35.8 | 1.501 | 2.044 | 1.282 | 13.003 | 12.269 | 0.503 | 0.166 | 0.216 | 61.321 | 6.715 |
| Total Non-Current Liabilities
| 122.509 | 170.864 | 82.727 | 42.88 | 15.418 | 13.003 | 12.269 | 0.503 | 0.166 | 0.216 | 61.321 | 6.715 |
| Total Liabilities
| 264.735 | 249.78 | 188.513 | 125.781 | 52.161 | 52.982 | 39.915 | 10.178 | 9.875 | 2.94 | 62.845 | 8.017 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 61.091 | 6.711 |
| Common Stock
| 0.011 | 0.01 | 0.009 | 0.008 | 0.006 | 0.005 | 0.003 | 0.003 | 0.003 | 0.002 | 0.001 | 0.001 |
| Retained Earnings
| -1,969.15 | -1,693.024 | -1,464.722 | -1,124.581 | -817.961 | -527.349 | -296.65 | -177.159 | -98.11 | -40.889 | -12.883 | -4.11 |
| Accumulated Other Comprehensive Income/Loss
| -0.204 | -2.067 | -0.368 | 0.296 | 0.22 | -0.34 | -0.151 | -0.183 | -0.518 | -0.1 | -0.335 | -6.711 |
| Other Total Stockholders Equity
| 1,870.112 | 1,821.721 | 1,744.695 | 1,586.616 | 1,108.516 | 866.541 | 474.662 | 431.075 | 413.725 | 139.169 | -58.891 | 0.382 |
| Total Shareholders Equity
| -99.231 | 126.64 | 279.614 | 462.339 | 290.781 | 338.857 | 177.864 | 253.736 | 315.1 | 103.182 | -11.017 | -3.727 |
| Total Equity
| -99.231 | 126.64 | 279.614 | 462.339 | 290.781 | 338.857 | 177.864 | 253.736 | 315.1 | 103.182 | -11.017 | -3.727 |
| Total Liabilities & Shareholders Equity
| 165.504 | 376.42 | 468.127 | 588.12 | 342.942 | 391.839 | 217.779 | 263.914 | 324.975 | 106.122 | 51.828 | 4.29 |